If You Change Your Diet, Will Your Cholesterol Drop? Depends on Your Genetics

 

At the KAHN CENTER, we teach that low-density lipoprotein cholesterol (LDL-C) is a causal risk factor for atherosclerotic cardiovascular disease (ASCVD). Guidelines recommend reducing dietary saturated fat intake to lower LDL-C, but dietary effects can vary a lot in our patients. Why is that?

A new study examined whether genetic propensity for higher LDL-C modifies the association of saturated fat intake with LDL-C and incident ASCVD.

STUDY

Among 20,940 Women’s Health Initiative participants with genetic information, the authors examined dietary saturated fat intake from food frequency questionnaires and a polygenic score for higher LDL-C (PGS).  The primary outcome was LDL-C. The secondary outcome was incident ASCVD. 

RESULTS

The association between saturated fat intake and LDL-C was modified by the PGS, meaning not all patients get the same response to lower dietary saturated fat.
 
Among 16,835 participants without prevalent ASCVD, 1,582 experienced incident ASCVD over 10 years time.
 
A 5% isocaloric increase in saturated fat intake was associated with a higher ASCVD risk among individuals in the top quartile of PGS. 

CONCLUSIONS

This study helps explain why 2 patients substituting beans in place of beef, olive oil in place of butter, tofu in place of eggs, and soy milk in place of 2% cow milk may have very different follow-up reductions in LDL-C.
 
The association between saturated fat intake and LDL-C and subsequent ASCVD risk may be stronger for individuals with a genetic propensity towards high LDL-C. 
 
Those at higher risk for LDL-C elevation on a genetic basis also see the most benefit in their lab results to lowering dietary saturated fats.
 
The main sources of dietary saturated fat to reduce in the diet come from full fat dairy and butter, red and processed meats, poultry, baked goods, and tropical oils like coconut.  It is worth reducing or eliminating these as much as possible and evaluating the results in lab work in 2 months. 
 
Their is availability of running a PGS at the KAHN CENTER and determining if you have a higher LDL-C based on genetics. 
Author
Dr. Joel Kahn

You Might Also Enjoy...

MORE EVIDENCE CORONARY ARTERY PLAQUE CAN BE REVERSED!

Question Does more intensive lipid-lowering therapy lead to greater regression of coronary atherosclerotic plaque across the entire coronary tree compared with intensive therapy in statin-naive patients with stable CAD?